Logo image of CS.PA

AXA SA (CS.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:CS - FR0000120628 - Common Stock

40.96 EUR
-0.18 (-0.44%)
Last: 12/31/2025, 7:00:00 PM
Fundamental Rating

5

CS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 47 industry peers in the Insurance industry. CS has only an average score on both its financial health and profitability. CS scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, CS could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CS was profitable.
In the past year CS had a positive cash flow from operations.
CS had positive earnings in each of the past 5 years.
CS had a positive operating cash flow in each of the past 5 years.
CS.PA Yearly Net Income VS EBIT VS OCF VS FCFCS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

The Return On Assets of CS (1.18%) is comparable to the rest of the industry.
The Return On Equity of CS (16.72%) is better than 68.09% of its industry peers.
CS has a Return On Invested Capital (1.28%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CS is in line with the industry average of 2.63%.
Industry RankSector Rank
ROA 1.18%
ROE 16.72%
ROIC 1.28%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
CS.PA Yearly ROA, ROE, ROICCS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 8.52%, CS perfoms like the industry average, outperforming 51.06% of the companies in the same industry.
In the last couple of years the Profit Margin of CS has grown nicely.
CS has a Operating Margin of 11.47%. This is comparable to the rest of the industry: CS outperforms 53.19% of its industry peers.
CS's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.47%
PM (TTM) 8.52%
GM N/A
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
CS.PA Yearly Profit, Operating, Gross MarginsCS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CS is destroying value.
Compared to 1 year ago, CS has less shares outstanding
The number of shares outstanding for CS has been reduced compared to 5 years ago.
Compared to 1 year ago, CS has a worse debt to assets ratio.
CS.PA Yearly Shares OutstandingCS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CS.PA Yearly Total Debt VS Total AssetsCS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

2.2 Solvency

CS has an Altman-Z score of 0.35. This is a bad value and indicates that CS is not financially healthy and even has some risk of bankruptcy.
CS has a Altman-Z score of 0.35. This is amongst the best in the industry. CS outperforms 87.23% of its industry peers.
The Debt to FCF ratio of CS is 1.41, which is an excellent value as it means it would take CS, only 1.41 years of fcf income to pay off all of its debts.
CS's Debt to FCF ratio of 1.41 is fine compared to the rest of the industry. CS outperforms 74.47% of its industry peers.
CS has a Debt/Equity ratio of 0.65. This is a neutral value indicating CS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.65, CS perfoms like the industry average, outperforming 51.06% of the companies in the same industry.
Although CS does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 1.41
Altman-Z 0.35
ROIC/WACC0.12
WACC10.7%
CS.PA Yearly LT Debt VS Equity VS FCFCS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

CS has a Current Ratio of 0.82. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CS (0.82) is better than 87.23% of its industry peers.
CS has a Quick Ratio of 0.82. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
CS has a Quick ratio of 0.82. This is amongst the best in the industry. CS outperforms 87.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
CS.PA Yearly Current Assets VS Current LiabilitesCS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

CS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.70%, which is quite good.
Measured over the past years, CS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.09% on average per year.
The Revenue has been growing slightly by 4.40% in the past year.
The Revenue has been decreasing by -8.16% on average over the past years.
EPS 1Y (TTM)8.7%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%8.56%
Revenue 1Y (TTM)4.4%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%3.72%

3.2 Future

The Earnings Per Share is expected to grow by 6.92% on average over the next years.
Based on estimates for the next years, CS will show a quite strong growth in Revenue. The Revenue will grow by 8.53% on average per year.
EPS Next Y12.47%
EPS Next 2Y9.09%
EPS Next 3Y8.52%
EPS Next 5Y6.92%
Revenue Next Year9.09%
Revenue Next 2Y6.99%
Revenue Next 3Y6.85%
Revenue Next 5Y8.53%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CS.PA Yearly Revenue VS EstimatesCS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B
CS.PA Yearly EPS VS EstimatesCS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.92, the valuation of CS can be described as reasonable.
Based on the Price/Earnings ratio, CS is valued cheaper than 80.85% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.51. CS is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 9.59 indicates a reasonable valuation of CS.
Based on the Price/Forward Earnings ratio, CS is valued cheaper than 80.85% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.13. CS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.92
Fwd PE 9.59
CS.PA Price Earnings VS Forward Price EarningsCS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CS is valued cheaply inside the industry as 87.23% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.16
EV/EBITDA N/A
CS.PA Per share dataCS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

CS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.88
PEG (5Y)0.6
EPS Next 2Y9.09%
EPS Next 3Y8.52%

6

5. Dividend

5.1 Amount

CS has a Yearly Dividend Yield of 5.23%, which is a nice return.
CS's Dividend Yield is a higher than the industry average which is at 3.90.
CS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
Industry RankSector Rank
Dividend Yield 5.23%

5.2 History

On average, the dividend of CS grows each year by 8.12%, which is quite nice.
Dividend Growth(5Y)8.12%
Div Incr Years4
Div Non Decr Years4
CS.PA Yearly Dividends per shareCS.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

61.79% of the earnings are spent on dividend by CS. This is not a sustainable payout ratio.
The dividend of CS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP61.79%
EPS Next 2Y9.09%
EPS Next 3Y8.52%
CS.PA Yearly Income VS Free CF VS DividendCS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
CS.PA Dividend Payout.CS.PA Dividend Payout, showing the Payout Ratio.CS.PA Dividend Payout.PayoutRetained Earnings

AXA SA

EPA:CS (12/31/2025, 7:00:00 PM)

40.96

-0.18 (-0.44%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners40.12%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap86.98B
Revenue(TTM)89.27B
Net Income(TTM)7.61B
Analysts82.96
Price Target45.55 (11.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.23%
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP61.79%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.4%
PT rev (3m)0.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.26%
EPS NY rev (3m)-1.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)0.24%
Valuation
Industry RankSector Rank
PE 10.92
Fwd PE 9.59
P/S 0.97
P/FCF 4.16
P/OCF 4.07
P/B 1.91
P/tB 3.61
EV/EBITDA N/A
EPS(TTM)3.75
EY9.16%
EPS(NY)4.27
Fwd EY10.43%
FCF(TTM)9.85
FCFY24.06%
OCF(TTM)10.08
OCFY24.6%
SpS42.04
BVpS21.42
TBVpS11.35
PEG (NY)0.88
PEG (5Y)0.6
Graham Number42.51
Profitability
Industry RankSector Rank
ROA 1.18%
ROE 16.72%
ROCE 1.62%
ROIC 1.28%
ROICexc 1.33%
ROICexgc 1.74%
OM 11.47%
PM (TTM) 8.52%
GM N/A
FCFM 23.44%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexgc growth 3Y10.47%
ROICexgc growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 1.41
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.53%
Interest Coverage 1.98
Cash Conversion N/A
Profit Quality 275.1%
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z 0.35
F-Score7
WACC10.7%
ROIC/WACC0.12
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)8.7%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%8.56%
EPS Next Y12.47%
EPS Next 2Y9.09%
EPS Next 3Y8.52%
EPS Next 5Y6.92%
Revenue 1Y (TTM)4.4%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%3.72%
Revenue Next Year9.09%
Revenue Next 2Y6.99%
Revenue Next 3Y6.85%
Revenue Next 5Y8.53%
EBIT growth 1Y7.05%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.92%
EBIT Next 3Y11.14%
EBIT Next 5YN/A
FCF growth 1Y150.74%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y145.39%
OCF growth 3Y7.85%
OCF growth 5Y9.48%

AXA SA / CS.PA FAQ

What is the ChartMill fundamental rating of AXA SA (CS.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CS.PA.


What is the valuation status of AXA SA (CS.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to AXA SA (CS.PA). This can be considered as Fairly Valued.


What is the profitability of CS stock?

AXA SA (CS.PA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for CS stock?

The Price/Earnings (PE) ratio for AXA SA (CS.PA) is 10.92 and the Price/Book (PB) ratio is 1.91.


What is the financial health of AXA SA (CS.PA) stock?

The financial health rating of AXA SA (CS.PA) is 5 / 10.